STALLION Stallion India Fluorochemicals Q4 FY26 results (Jan–Mar 2026) and concall
Stallion India Fluorochemicals Ltd. reported robust financial performance for FY26, with significant year-on-year growth in revenue, EBITDA, and PAT, surpassing internal targets. The company made strategic progress with environmental clearance for its Bhilwara R-32 plant and nearing commissioning of Khalapur and Mumbattu facilities. However, Q4 FY26 saw a sequential revenue decline, and management acknowledged ongoing geopolitical and supply chain challenges.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 27.6%, net profit down 15.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 68 | 85 | 152 | 110 | 106 +56% | 105 +24% | 110 −28% |
| EBITDA | 2 | 14 | 19 | 14 | 16 +700% | 12 −14% | 16 −16% |
| Net profit | 1 | 10 | 13 | 10 | 11 +1000% | 11 +10% | 11 −15% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





